Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.55
Bid: 129.05
Ask: 129.10
Change: 1.55 (1.22%)
Spread: 0.05 (0.039%)
Open: 127.90
High: 131.00
Low: 126.90
Prev. Close: 127.00
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

17 Mar 2020 07:00

RNS Number : 4192G
Centrica PLC
17 March 2020
 

17 March 2020

 

Centrica plc ('the Company')

 

Board changes

 

 

Charles Berry to step down as Centrica Chairman

Scott Wheway confirmed as Charles' successor

Chris O'Shea appointed Interim Group Chief Executive

Iain Conn to step down as CEO and from the Board

 

Centrica plc ("Centrica") announces that its Chairman, Charles Berry, who has been on medical leave since the 12 February 2020, has tendered his resignation with immediate effect. Charles' decision follows advice from doctors to reduce his workload.

 

The Company therefore confirms the appointment of Scott Wheway as its Chairman, effective immediately. Scott has been a Non-Executive Director of Centrica since 2016 and acting Chairman since 12 February 2020, and is a well-qualified successor to Charles, with deep knowledge of the Company, strong plc Board experience and in-depth customer facing pedigree.

 

Charles Berry said: "It has been a great honour to Chair Centrica, but when the doctor tells you to reduce your workload, you are wise to listen. I wish everyone at Centrica great success in the future."

 

The Board would like to thank Charles for his service to Centrica. We wish him a swift and full recovery from his recent ill health and greatly appreciate his contribution to the company's repositioning during his tenure.

 

Centrica also announces that Chris O'Shea, currently Group Chief Financial Officer (CFO), will become Interim Group Chief Executive (CEO) while the search for a permanent CEO continues. Iain Conn will step down as CEO and from the Board from today. He will remain available until the Annual General Meeting on 11 May 2020, as anticipated, to support the handover but the day to day leadership of the Company will pass to Chris.

 

Scott Wheway said "I'm acutely aware that I'm taking this role at a time when we need to navigate our way through the current volatility caused by the impact of Coronavirus. Protecting our employees and customers is a priority for us, particularly those who are vulnerable. As a business we remain focussed on structural simplification, improving our efficiency and delivering growth in our customer facing businesses. 

 

"I will immediately be concentrating on completing the search for a CEO for Centrica, which includes both internal and external candidates. In the meantime, I have asked Chris O'Shea to take over as Interim CEO until that search is concluded. Chris is an experienced CFO with a strong track record of cost efficiency and financial discipline, and I will work closely with him during this period.

 

"On behalf of the Board, I would like to thank Iain for his continued commitment and resilience in the face of unprecedented challenges during his tenure as CEO. Iain has led the repositioning of the company back towards the customer and towards a lower carbon future and has delivered significant portfolio simplification, debt reduction and cost efficiency. The Board wishes Iain well and thanks him for his contribution."

 

The information communicated in this announcement is inside information.

 

ENDS

 

Enquiries:

 

Investors/analysts 01753 494900 ir@centrica.com

 

Media 01784 843000 media@centrica.com

 

Notes

 

Following his appointment as Chairman, Scott Wheway has stepped down and Stephen Hester will replace him as Chair of the Centrica Remuneration Committee with immediate effect.

 

Scott Wheway is currently Senior Independent Director and Responsible Banking Committee Chair at Santander UK. He will relinquish his committee chair responsibilities immediately and exit his position at Santander UK following the completion of the process to select a new chair. It is anticipated that this should happen by the end of the summer.

 

Scott will retain his current position as Chairman of AXA UK plc.

 

Remuneration

 

Scott Wheway will receive an annual fee of £410,000. Scott will not be eligible to receive any pension or cash in lieu of pension allowance or participate in any discretionary compensation plans or long-term incentive plans.

 

As announced on 30 July 2019, Iain Conn will be treated in accordance with Centrica's approved remuneration policy and his service contract for the remaining term of his employment. Full details of remuneration payable to Iain Conn have been disclosed on the Centrica website in compliance with Section 430(2B) of the Companies Act 2006 and will be disclosed in the Company's Annual Report and Accounts for the year ending 31 December 2020.

 

Chris O'Shea will receive a salary supplement of £100,000, pro-rated, while he is Interim CEO.

 

Centrica plc is listed on the London Stock Exchange (CNA) Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654 Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAJRMFTMTABMIM
Date   Source Headline
21st Feb 20235:45 pmRNSTransaction in Own Shares
21st Feb 20232:30 pmRNSDirector/PDMR Shareholding
20th Feb 20235:40 pmRNSTransaction in Own Shares
17th Feb 20235:30 pmRNSTransaction in Own Shares
16th Feb 20235:30 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSFinal Results
15th Feb 20235:45 pmRNSTransaction in Own Shares
14th Feb 20235:55 pmRNSTransaction in Own Shares
13th Feb 20235:50 pmRNSTransaction in Own Shares
13th Feb 20232:30 pmRNSDirector/PDMR Shareholding
10th Feb 20235:40 pmRNSTransaction in Own Shares
9th Feb 20236:00 pmRNSTransaction in Own Shares
8th Feb 20236:00 pmRNSTransaction in Own Shares
7th Feb 20235:50 pmRNSTransaction in Own Shares
6th Feb 20235:40 pmRNSTransaction in Own Shares
3rd Feb 20235:50 pmRNSTransaction in Own Shares
2nd Feb 20235:40 pmRNSTransaction in Own Shares
1st Feb 20235:50 pmRNSTransaction in Own Shares
1st Feb 20232:30 pmRNSTotal Voting Rights
31st Jan 20235:40 pmRNSTransaction in Own Shares
30th Jan 20235:50 pmRNSTransaction in Own Shares
27th Jan 20235:30 pmRNSTransaction in Own Shares
26th Jan 20235:40 pmRNSTransaction in Own Shares
25th Jan 20235:50 pmRNSTransaction in Own Shares
25th Jan 20231:15 pmRNSDirector/PDMR Shareholding
24th Jan 20235:30 pmRNSTransaction in Own Shares
23rd Jan 20235:30 pmRNSTransaction in Own Shares
20th Jan 20235:50 pmRNSTransaction in Own Shares
19th Jan 20235:30 pmRNSTransaction in Own Shares
18th Jan 20235:30 pmRNSTransaction in Own Shares
17th Jan 20235:45 pmRNSTransaction in Own Shares
16th Jan 20235:45 pmRNSTransaction in Own Shares
13th Jan 20235:30 pmRNSTransaction in Own Shares
12th Jan 20235:30 pmRNSTransaction in Own Shares
12th Jan 20237:00 amRNSDirectorate Change
12th Jan 20237:00 amRNSTrading Update
11th Jan 20235:30 pmRNSTransaction in Own Shares
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
10th Jan 20235:50 pmRNSTransaction in Own Shares
9th Jan 20235:50 pmRNSTransaction in Own Shares
6th Jan 20235:30 pmRNSTransaction in Own Shares
5th Jan 20235:30 pmRNSTransaction in Own Shares
4th Jan 20235:40 pmRNSTransaction in Own Shares
4th Jan 20234:00 pmRNSTotal Voting Rights
3rd Jan 20235:40 pmRNSTransaction in Own Shares
30th Dec 20221:30 pmRNSTransaction in Own Shares
29th Dec 20225:40 pmRNSTransaction in Own Shares
28th Dec 20226:15 pmRNSTransaction in Own Shares
28th Dec 20225:15 pmRNSDirector/PDMR Shareholding
23rd Dec 20221:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.